Review
Published on 08 Jul 2021
In situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.671589
- 16,067 views
- 29 citations
Type at least 3 characters
608 articles
Original Research
Published on 07 Jul 2021
Phenylethanoid Glycosides From Callicarpa kwangtungensis Chun Attenuate TNF-α-Induced Cell Damage by Inhibiting NF-κB Pathway and Enhancing Nrf2 Pathway in A549 Cells
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.693983
- 4,069 views
- 19 citations
Review
Published on 05 Jul 2021
Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.692551
- 10,907 views
- 26 citations
Original Research
Published on 05 Jul 2021
The Specific Connexin 43–Inhibiting Peptide Gap26 Improved Alveolar Development of Neonatal Rats With Hyperoxia Exposure
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.587267
- 3,090 views
- 7 citations
Original Research
Published on 29 Jun 2021
Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.704316
- 9,374 views
- 17 citations
Review
Published on 29 Jun 2021
Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.691621
- 10,102 views
- 27 citations
Review
Published on 29 Jun 2021
The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.698905
- 25,559 views
- 45 citations
Original Research
Published on 28 Jun 2021
Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.668825
- 6,677 views
- 16 citations
Original Research
Published on 23 Jun 2021
Systemic Administration of Tempol Attenuates the Cardiorespiratory Depressant Effects of Fentanyl
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.690407
- 3,814 views
- 23 citations
Original Research
Published on 23 Jun 2021
Allergic Asthma-Induced Cognitive Impairment is Alleviated by Dexamethasone
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.680815
- 13,924 views
- 25 citations
Original Research
Published on 18 Jun 2021
Exploring the Mechanism Whereby Sinensetin Delays the Progression of Pulmonary Fibrosis Based on Network Pharmacology and Pulmonary Fibrosis Models
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.693061
- 4,457 views
- 13 citations
Original Research
Published on 17 Jun 2021
Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.669642
- 9,263 views
- 79 citations
Original Research
Published on 17 Jun 2021
Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.666600
- 17,633 views
- 81 citations
Review
Published on 14 Jun 2021
Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.659577
- 18,594 views
- 36 citations
Original Research
Published on 11 Jun 2021
AGR3 Regulates Airway Epithelial Junctions in Patients with Frequent Exacerbations of COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.669403
- 3,180 views
- 10 citations
Original Research
Published on 08 Jun 2021
Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.675907
- 3,767 views
- 11 citations